AnaptysBio (ANAB) PT Lowered to $93 at Piper Sandler
Tweet
Share
E-mailGet Alerts ANAB Hot Sheet
Price: $59.43 -0.93%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE
Piper Sandler analyst Yasmeen Rahimi lowered the price target on AnaptysBio (NASDAQ: ANAB) to $93.00 (from $95.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Natera (NTRA) PT Raised to $270 at BTIG
- Darling Ingredients (DAR) PT Lowered to $70 at TD Cowen
- Constellation Brands (STZ) PT Lowered to $157 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
